Cargando…
Genome-wide identification of cancer-specific alternative splicing in circRNA
Circular RNA (circRNA) is a group of RNA families generated by RNA circularization, which was discovered ubiquitously across different cancers. However, the internal structure of circRNA is difficult to determine due to alternative splicing that occurs in its exons and introns. Furthermore, cancer-s...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408762/ https://www.ncbi.nlm.nih.gov/pubmed/30849979 http://dx.doi.org/10.1186/s12943-019-0996-0 |
_version_ | 1783401842211815424 |
---|---|
author | Feng, Jing Chen, Ke Dong, Xin Xu, Xiaolong Jin, Yuxuan Zhang, Xinyang Chen, Wenbo Han, Yujing Shao, Lin Gao, Yang He, Chunjiang |
author_facet | Feng, Jing Chen, Ke Dong, Xin Xu, Xiaolong Jin, Yuxuan Zhang, Xinyang Chen, Wenbo Han, Yujing Shao, Lin Gao, Yang He, Chunjiang |
author_sort | Feng, Jing |
collection | PubMed |
description | Circular RNA (circRNA) is a group of RNA families generated by RNA circularization, which was discovered ubiquitously across different cancers. However, the internal structure of circRNA is difficult to determine due to alternative splicing that occurs in its exons and introns. Furthermore, cancer-specific alternative splicing of circRNA is less likely to be identified. Here, we proposed a de novo algorithm, CircSplice, that could identify internal alternative splicing in circRNA and compare differential circRNA splicing events between different conditions (http://gb.whu.edu.cn/CircSplice or https://github.com/GeneFeng/CircSplice). By applying CircSplice in clear cell renal cell carcinoma and bladder cancer, we detected 4498 and 2977 circRNA alternative splicing (circ-AS) events in the two datasets respectively and confirmed the expression of circ-AS events by RT-PCR. We further inspected the distributions and patterns of circ-AS in cancer and adjacent normal tissues. To further understand the potential functions of cancer-specific circ-AS, we classified those events into tumor suppressors and oncogenes and performed pathway enrichment analysis. This study is the first comprehensive view of cancer-specific circRNA alternative splicing, which could contribute significantly to regulation and functional research of circRNAs in cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-019-0996-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6408762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64087622019-03-21 Genome-wide identification of cancer-specific alternative splicing in circRNA Feng, Jing Chen, Ke Dong, Xin Xu, Xiaolong Jin, Yuxuan Zhang, Xinyang Chen, Wenbo Han, Yujing Shao, Lin Gao, Yang He, Chunjiang Mol Cancer Letter to Editor Circular RNA (circRNA) is a group of RNA families generated by RNA circularization, which was discovered ubiquitously across different cancers. However, the internal structure of circRNA is difficult to determine due to alternative splicing that occurs in its exons and introns. Furthermore, cancer-specific alternative splicing of circRNA is less likely to be identified. Here, we proposed a de novo algorithm, CircSplice, that could identify internal alternative splicing in circRNA and compare differential circRNA splicing events between different conditions (http://gb.whu.edu.cn/CircSplice or https://github.com/GeneFeng/CircSplice). By applying CircSplice in clear cell renal cell carcinoma and bladder cancer, we detected 4498 and 2977 circRNA alternative splicing (circ-AS) events in the two datasets respectively and confirmed the expression of circ-AS events by RT-PCR. We further inspected the distributions and patterns of circ-AS in cancer and adjacent normal tissues. To further understand the potential functions of cancer-specific circ-AS, we classified those events into tumor suppressors and oncogenes and performed pathway enrichment analysis. This study is the first comprehensive view of cancer-specific circRNA alternative splicing, which could contribute significantly to regulation and functional research of circRNAs in cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-019-0996-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-08 /pmc/articles/PMC6408762/ /pubmed/30849979 http://dx.doi.org/10.1186/s12943-019-0996-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to Editor Feng, Jing Chen, Ke Dong, Xin Xu, Xiaolong Jin, Yuxuan Zhang, Xinyang Chen, Wenbo Han, Yujing Shao, Lin Gao, Yang He, Chunjiang Genome-wide identification of cancer-specific alternative splicing in circRNA |
title | Genome-wide identification of cancer-specific alternative splicing in circRNA |
title_full | Genome-wide identification of cancer-specific alternative splicing in circRNA |
title_fullStr | Genome-wide identification of cancer-specific alternative splicing in circRNA |
title_full_unstemmed | Genome-wide identification of cancer-specific alternative splicing in circRNA |
title_short | Genome-wide identification of cancer-specific alternative splicing in circRNA |
title_sort | genome-wide identification of cancer-specific alternative splicing in circrna |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408762/ https://www.ncbi.nlm.nih.gov/pubmed/30849979 http://dx.doi.org/10.1186/s12943-019-0996-0 |
work_keys_str_mv | AT fengjing genomewideidentificationofcancerspecificalternativesplicingincircrna AT chenke genomewideidentificationofcancerspecificalternativesplicingincircrna AT dongxin genomewideidentificationofcancerspecificalternativesplicingincircrna AT xuxiaolong genomewideidentificationofcancerspecificalternativesplicingincircrna AT jinyuxuan genomewideidentificationofcancerspecificalternativesplicingincircrna AT zhangxinyang genomewideidentificationofcancerspecificalternativesplicingincircrna AT chenwenbo genomewideidentificationofcancerspecificalternativesplicingincircrna AT hanyujing genomewideidentificationofcancerspecificalternativesplicingincircrna AT shaolin genomewideidentificationofcancerspecificalternativesplicingincircrna AT gaoyang genomewideidentificationofcancerspecificalternativesplicingincircrna AT hechunjiang genomewideidentificationofcancerspecificalternativesplicingincircrna |